“As part of the review of the regular pandemic summary safety reports for Vaxzevria, AstraZeneca’s Covid-19 vaccine, the PRAC is analysing data provided by the marketing authorisation holder on cases … Continue reading Europe: EMA assessing reports of Guillain-Barre syndrome with AstraZeneca’s coronavirus vaccine VaxZevria
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed